Lobe Sciences Ltd. (CVE:LOBE) | Finanzwire

Basculer en Français

10933	Companies
238714	Keywords
167504	Articles
128261	Press releases

Home
Companies
Lobe Sciences Ltd.

BRIEF

published on 09/01/2026 at 01:05, 3 days 11 hours ago

Lobe Sciences Ltd. Completes Private Placement Upsize

Private Placement Clinical Trials Biopharmaceutical Lobe Sciences Sickle Cell
PRESS RELEASE

published on 09/01/2026 at 01:00, 3 days 11 hours ago

Lobe Sciences Ltd. Announces Closing of Upsize to Non-Brokered Private Placement
Lobe Sciences Ltd. announces closure of second tranche of non-brokered private placement offering, raising $60,000 for therapeutic development programs

Private Placement Biopharmaceutical Company Therapeutic Development Lobe Sciences Ltd. S-100 Drug Candidate
BRIEF

published on 08/29/2026 at 01:05, 6 days 11 hours ago

Lobe Sciences Ltd. Upsizes Private Placement

Private Placement Biopharmaceutical Regulatory Approval Capital Raising S-100 Drug
PRESS RELEASE

published on 08/29/2026 at 01:00, 6 days 11 hours ago

Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Lobe Sciences Ltd. announces upsize to non-brokered private placement offering, intending to raise gross proceeds of $60,000 for advancing therapeutic programs. Proceeds to be used for S-100 drug candidate and subsidiary development

Private Placement Clinical Trials Lobe Sciences Ltd. Therapeutic Programs S-100 Drug Candidate
BRIEF

published on 08/28/2026 at 14:05, 6 days 22 hours ago

Lobe Sciences Appoints New CFO Amid Strategic Growth

Life Sciences Leadership Transition New CFO Lobe Sciences Psilocin Therapeutic
PRESS RELEASE

published on 08/28/2026 at 14:00, 6 days 22 hours ago

Lobe Sciences Expands Leadership Team with New CFO Appointment
Dr. David Kideckel, PhD, MBA, appointed as CFO of Lobe Sciences Ltd., bringing expertise in life sciences and capital markets. Mirza Rahimani transitions to Vice President of Finance

Chief Financial Officer Pharmaceutical Industry Lobe Sciences Ltd. Mirza Rahimani Dr. David Kideckel
BRIEF

published on 08/20/2026 at 14:05, 14 days 22 hours ago

Lobe Sciences Ltd. Concludes $2.1 Million Private Placement

Private Placement Clinical Trials Biopharmaceutical Lobe Sciences S-100 Candidate
PRESS RELEASE

published on 08/20/2026 at 14:00, 14 days 22 hours ago

Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement
Lobe Sciences Ltd. announces closing of non-brokered private placement offering of Common Shares. Proceeds for working capital and therapeutic development programs including S-100 drug candidate

Common Shares Private Placement Offering Therapeutic Development Lobe Sciences Ltd. S-100 Drug Candidate
BRIEF

published on 08/18/2026 at 14:05, 16 days 22 hours ago

Lobe Sciences Releases Third Quarter 2026 Financial Results

Private Placement Financial Results R&D Investment Equity Changes Sickle Cell Program
PRESS RELEASE

published on 08/18/2026 at 14:00, 16 days 22 hours ago

Lobe Sciences Reports Third Quarter 2026 Financial Results
Lobe Sciences Ltd. announces unaudited financial results for Q3 2026, showing progress in R&D and capital allocation. Equity position increased. Private placements closed and announced. Subsidiaries focusing on drugs for neurological and psychiatric disorders

Financial Results Private Placements R&D Neurological Disorders Lobe Sciences Ltd.

1 2 ... 8

Accesswire

Published on 09/04/2026 at 08:02, 4 hours 41 minutes ago

Southern Energy Corp. Announces Restricted Share Award Grant
Published on 09/03/2026 at 22:30, 14 hours 13 minutes ago

Hillcrest Closes Debt Settlement
Published on 09/03/2026 at 17:55, 18 hours 48 minutes ago

ACCESS Newswire to Participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference in New York on September 10, 2026
Published on 09/03/2026 at 15:00, 21 hours 43 minutes ago

Arcus & Core Mobilize for 3,000 Metre Drilling Program at the Touleary VMS Project
Published on 09/03/2026 at 15:00, 21 hours 43 minutes ago

Arcus & Core Mobilize for 3,000 Metre Drilling Program at the Touleary VMS Project

View all ACCESSWIRE

EQS Group

Published on 09/04/2026 at 12:15, 28 minutes ago

Warren Wise checks Symrise: A beast of a profit or a bitter aftertaste?
Published on 09/04/2026 at 11:55, 48 minutes ago

ANTHBOT R7 Series Brings True Zero-Edge Trimming to Robot Mowing
Published on 09/04/2026 at 11:44, 59 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 09/04/2026 at 11:34, 1 hour 9 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 09/04/2026 at 11:02, 1 hour 41 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter

Les Echos

Published on 09/04/2026 at 08:29, 4 hours 14 minutes ago

ENGIE exceeds 10 GW of storage capacity worldwide, driven by summer growth in BESS across Europe
Published on 09/03/2026 at 18:40, 18 hours 3 minutes ago

Mersen: Number of shares and voting rights as of August 31, 2026
Published on 09/03/2026 at 18:10, 18 hours 33 minutes ago

Eiffage wins the contract to build two steel structures part of the new Merwede Bridge in the Netherlands
Published on 09/03/2026 at 18:02, 18 hours 40 minutes ago

Total number of voting rights and shares making up the share capital at August 31, 2026
Published on 09/03/2026 at 18:00, 18 hours 43 minutes ago

Kerlink and DataPrint Announce Distribution Partnership To Expand LoRaWAN® Adoption Across France

View all LES ECHOS COMFI WIRE